TY - JOUR
T1 - Biological prognostic factors in neuroblastoma
T2 - Experience of the Institut Gustave Roussy
AU - Benard, J.
AU - Bourhis, J.
AU - Hartmann, O.
AU - Terrier-Lacombe, M. J.
AU - Brugieres, L.
AU - De Vathaire, F.
AU - Lemerle, J.
AU - Riou, G.
PY - 1993/12/1
Y1 - 1993/12/1
N2 - The study carried out on 59 neuroblastoma indicates that when MYCN and diploidy content are present in the same tumor, clinical outcome of patients with localized neuroblastoma (stage I, II, III), IVS-stage and patients under one year of age is still poorer. Thus, the determination of MYCN genomic content and DNA index in routine will help the paediatric oncologist in the clinical management of these patients.
AB - The study carried out on 59 neuroblastoma indicates that when MYCN and diploidy content are present in the same tumor, clinical outcome of patients with localized neuroblastoma (stage I, II, III), IVS-stage and patients under one year of age is still poorer. Thus, the determination of MYCN genomic content and DNA index in routine will help the paediatric oncologist in the clinical management of these patients.
KW - MYCN amplification
KW - Neuroblastoma
KW - Ploidy DNA index
KW - Prognosis
UR - http://www.scopus.com/inward/record.url?scp=0027739827&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0027739827
SN - 0892-2187
VL - 5
SP - 321
EP - 325
JO - Clinical Chemistry and Enzymology Communications
JF - Clinical Chemistry and Enzymology Communications
IS - 4-6
ER -